Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 776

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 776
---
20.50 
 62.50 |     | Expiry date      
 April 14, 2027   
 March 28, 2025   |
|:-----------------------------|:----|:---------------------|----:|:----|:----------------|------:|:----|:-----------------|
| 2020 Investor warrants       |     |                      |  65 |     |                 | 50.00 |     | August 16, 2024  |
| NBTS Warrants                |     |                      |   3 |     |                 | 54.50 |     | June 19, 2025    |
| 2022 April Agent warrants    |     |                      |  32 |     |                 | 33.12 |     | October 14, 2026 |
| 2022 Agent warrants          |     |                      |  12 |     |                 | 78.12 |     | March 28, 2025   |
|                              |     |                      | 677 |     |                 |       |     |                  |

Series C preferred stock warrants

In connection with the Series C Preferred Stock private placement, the Company issued 2,504 Series C Agent Warrants. The Series C Agent Warrants have an exercise price of $ 1,000 per share, provide for a cashless exercise feature, and are exercisable for a period of four years from August 19, 2020. The Series C Preferred Stock issuable upon exercise of the Series C Agent Warrants is convertible into shares of common stock in the same manner as each respective underlying series of outstanding Series C Preferred Stock and will be entitled to the same dividend rights as each respective series.

<div align='center'>F-24</div>

The following table sets forth changes in outstanding Series C Agent Warrants:

|                                               |     |     | Balance,June 30, 2023 |     |     | Number ofWarrants 
 Issued            |     |     | Number ofWarrants 
 Exercised         |     |     | Balance,June 30, 2024 |     |     | Exerciseprice$ |
|:----------------------------------------------|:----|:----|----------------------:|:----|:----|:------------------|:----|:----|:------------------|:----|:----|----------------------:|:----|:----|---------------:|
| Issuance of Preferred SeriesC-1Agent Warrants